Skip to main content
Erschienen in: Journal of Cardiovascular Translational Research 5/2012

01.10.2012

Cell Delivery Routes for Stem Cell Therapy to the Heart: Current and Future Approaches

verfasst von: Niall G. Campbell, Ken Suzuki

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

An important factor to determine the success of stem cell therapy to the heart is the choice of cell delivery route. This will affect the fate of donor cells and subsequently influence the outcome of treatment; however, there is currently no optimum cell delivery route appropriate for every disease condition or every donor cell type. This review summarises currently available approaches for administering cells to the heart, with a particular focus on cell retention/survival and the therapeutic benefits seen in preclinical and clinical studies. Two major approaches are intracoronary and intramyocardial injection, which have been widely used for the delivery of various types of cells. Although there are advantages to both approaches, donor cell retention and survival are poor using these methods, potentially limiting therapeutic effects. Various attempts to improve current approaches, along with the development of emerging new approaches, are also described and discussed in this review.
Literatur
1.
Zurück zum Zitat Siminiak, T., Kalawski, R., Fiszer, D., Jerzykowska, O., Rzezniczak, J., Rozwadowska, N., et al. (2004). Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. American Heart Journal, 148(3), 531–537.PubMedCrossRef Siminiak, T., Kalawski, R., Fiszer, D., Jerzykowska, O., Rzezniczak, J., Rozwadowska, N., et al. (2004). Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. American Heart Journal, 148(3), 531–537.PubMedCrossRef
2.
Zurück zum Zitat Zhao, Q., Sun, Y., Xia, L., Chen, A., & Wang, Z. (2008). Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. The Annals of Thoracic Surgery, 86(6), 1833–1840.PubMedCrossRef Zhao, Q., Sun, Y., Xia, L., Chen, A., & Wang, Z. (2008). Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. The Annals of Thoracic Surgery, 86(6), 1833–1840.PubMedCrossRef
3.
4.
Zurück zum Zitat Fukushima, S., Coppen, S. R., Lee, J., Yamahara, K., Felkin, L. E., Terracciano, C. M. N., et al. (2008). Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. PLoS One, 3(8), e3071.PubMedCrossRef Fukushima, S., Coppen, S. R., Lee, J., Yamahara, K., Felkin, L. E., Terracciano, C. M. N., et al. (2008). Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. PLoS One, 3(8), e3071.PubMedCrossRef
6.
Zurück zum Zitat Brasselet, C., Morichetti, M. C., Messas, E., Carrion, C., Bissery, A., Bruneval, P., et al. (2005). Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. European Heart Journal, 26(15), 1551–1556. doi:10.1093/eurheartj/ehi151.PubMedCrossRef Brasselet, C., Morichetti, M. C., Messas, E., Carrion, C., Bissery, A., Bruneval, P., et al. (2005). Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. European Heart Journal, 26(15), 1551–1556. doi:10.​1093/​eurheartj/​ehi151.PubMedCrossRef
7.
Zurück zum Zitat Thompson, C. A., Nasseri, B. A., Makower, J., Houser, S., McGarry, M., Lamson, T., et al. (2003). Percutaneous transvenous cellular cardiomyoplasty—a novel nonsurgical approach for myocardial cell transplantation. Journal of the American College of Cardiology, 41(11), 1964–1971. doi:10.1016/s0735-1097(03)00397-8.PubMedCrossRef Thompson, C. A., Nasseri, B. A., Makower, J., Houser, S., McGarry, M., Lamson, T., et al. (2003). Percutaneous transvenous cellular cardiomyoplasty—a novel nonsurgical approach for myocardial cell transplantation. Journal of the American College of Cardiology, 41(11), 1964–1971. doi:10.​1016/​s0735-1097(03)00397-8.PubMedCrossRef
8.
Zurück zum Zitat Ikeno, F., Lyons, J., Kaneda, H., Baluom, M., Benet, L. Z., & Rezaee, M. (2004). Novel percutaneous adventitial drug delivery system for regional vascular treatment. Catheterization and Cardiovascular Interventions, 63(2), 222–230.PubMedCrossRef Ikeno, F., Lyons, J., Kaneda, H., Baluom, M., Benet, L. Z., & Rezaee, M. (2004). Novel percutaneous adventitial drug delivery system for regional vascular treatment. Catheterization and Cardiovascular Interventions, 63(2), 222–230.PubMedCrossRef
9.
Zurück zum Zitat Penn, M. S., Ellis, S., Gandhi, S., Greenbaum, A., Hodes, Z., Mendelsohn, F. O., et al. (2012). Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study. Circulation Research, 110(2), 304–311.PubMedCrossRef Penn, M. S., Ellis, S., Gandhi, S., Greenbaum, A., Hodes, Z., Mendelsohn, F. O., et al. (2012). Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study. Circulation Research, 110(2), 304–311.PubMedCrossRef
10.
Zurück zum Zitat Medicetty, S., Wiktor, D., Lehman, N., Raber, A., Popovic, Z. B., Deans, R., et al. (2012). Percutaneous adventitial delivery of allogeneic bone marrow derived stem cells via infarct related artery improves long-term ventricular function in acute myocardial infarction. Cell Transplant. doi:10.3727/096368911x603657. Medicetty, S., Wiktor, D., Lehman, N., Raber, A., Popovic, Z. B., Deans, R., et al. (2012). Percutaneous adventitial delivery of allogeneic bone marrow derived stem cells via infarct related artery improves long-term ventricular function in acute myocardial infarction. Cell Transplant. doi:10.​3727/​096368911x603657​.
11.
Zurück zum Zitat Hou, D., Youssef, E. A., Brinton, T. J., Zhang, P., Rogers, P., Price, E. T., et al. (2005). Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation, 112(9 Suppl), I150–I156.PubMed Hou, D., Youssef, E. A., Brinton, T. J., Zhang, P., Rogers, P., Price, E. T., et al. (2005). Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation, 112(9 Suppl), I150–I156.PubMed
12.
Zurück zum Zitat George, J. C., Goldberg, J., Joseph, M., Abdulhameed, N., Crist, J., Das, H., et al. (2008). Transvenous intramyocardial cellular delivery increases retention in comparison to intracoronary delivery in a porcine model of acute myocardial infarction. Journal of Interventional Cardiology, 21(5), 424–431.PubMedCrossRef George, J. C., Goldberg, J., Joseph, M., Abdulhameed, N., Crist, J., Das, H., et al. (2008). Transvenous intramyocardial cellular delivery increases retention in comparison to intracoronary delivery in a porcine model of acute myocardial infarction. Journal of Interventional Cardiology, 21(5), 424–431.PubMedCrossRef
13.
Zurück zum Zitat Perin, E. C., Silva, G. V., Assad, J. A. R., Vela, D., Buja, L. M., Sousa, A. L. S., et al. (2008). Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. Journal of Molecular and Cellular Cardiology, 44(3), 486–495.PubMedCrossRef Perin, E. C., Silva, G. V., Assad, J. A. R., Vela, D., Buja, L. M., Sousa, A. L. S., et al. (2008). Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. Journal of Molecular and Cellular Cardiology, 44(3), 486–495.PubMedCrossRef
14.
Zurück zum Zitat Suzuki, K., Murtuza, B., Beauchamp, J. R., Brand, N. J., Barton, P. J., Varela-Carver, A., et al. (2004). Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation, 110(11 Suppl 1), II219–II224. doi:10.1161/01.CIR.0000138388.55416.06.PubMed Suzuki, K., Murtuza, B., Beauchamp, J. R., Brand, N. J., Barton, P. J., Varela-Carver, A., et al. (2004). Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation, 110(11 Suppl 1), II219–II224. doi:10.​1161/​01.​CIR.​0000138388.​55416.​06.PubMed
15.
Zurück zum Zitat Suzuki, K., Murtuza, B., Beauchamp, J. R., Smolenski, R. T., Varela-Carver, A., Fukushima, S., et al. (2004). Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. The FASEB Journal. doi:10.1096/fj.03-1308fje. 03-1308fje. Suzuki, K., Murtuza, B., Beauchamp, J. R., Smolenski, R. T., Varela-Carver, A., Fukushima, S., et al. (2004). Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. The FASEB Journal. doi:10.​1096/​fj.​03-1308fje. 03-1308fje.
16.
Zurück zum Zitat ukushima, S., Varela-Carver, A., Coppen, S. R., Yamahara, K., Felkin, L. E., Lee, J., et al. (2007). Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation, 115(17), 2254–2261. doi:10.1161/CIRCULATIONAHA.106.662577.PubMedCrossRef ukushima, S., Varela-Carver, A., Coppen, S. R., Yamahara, K., Felkin, L. E., Lee, J., et al. (2007). Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation, 115(17), 2254–2261. doi:10.​1161/​CIRCULATIONAHA.​106.​662577.PubMedCrossRef
17.
Zurück zum Zitat Veltman, C. E., Soliman, O. I. I., Geleijnse, M. L., Vletter, W. B., Smits, P. C., ten Cate, F. J., et al. (2008). Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy. European Heart Journal, 29(11), 1386–1396. doi:10.1093/eurheartj/ehn171.PubMedCrossRef Veltman, C. E., Soliman, O. I. I., Geleijnse, M. L., Vletter, W. B., Smits, P. C., ten Cate, F. J., et al. (2008). Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy. European Heart Journal, 29(11), 1386–1396. doi:10.​1093/​eurheartj/​ehn171.PubMedCrossRef
18.
Zurück zum Zitat Coppen, S. R., Fukushima, S., Shintani, Y., Takahashi, K., Varela-Carver, A., Salem, H., et al. (2008). A factor underlying late-phase arrhythmogenicity after cell therapy to the heart: global downregulation of connexin43 in the host myocardium after skeletal myoblast transplantation. Circulation, 118(14 Suppl), S138–S144. doi:10.1161/CIRCULATIONAHA.107.779629.PubMedCrossRef Coppen, S. R., Fukushima, S., Shintani, Y., Takahashi, K., Varela-Carver, A., Salem, H., et al. (2008). A factor underlying late-phase arrhythmogenicity after cell therapy to the heart: global downregulation of connexin43 in the host myocardium after skeletal myoblast transplantation. Circulation, 118(14 Suppl), S138–S144. doi:10.​1161/​CIRCULATIONAHA.​107.​779629.PubMedCrossRef
19.
Zurück zum Zitat Menasche, P., Alfieri, O., Janssens, S., McKenna, W., Reichenspurner, H., Trinquart, L., et al. (2008). The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation, 117(9), 1189–1200. doi:10.1161/CIRCULATIONAHA.107.734103.PubMedCrossRef Menasche, P., Alfieri, O., Janssens, S., McKenna, W., Reichenspurner, H., Trinquart, L., et al. (2008). The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation, 117(9), 1189–1200. doi:10.​1161/​CIRCULATIONAHA.​107.​734103.PubMedCrossRef
20.
Zurück zum Zitat Donndorf, P., Kundt, G., Kaminski, A., Yerebakan, C., Liebold, A., Steinhoff, G., et al. (2011). Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis. The Journal of Thoracic and Cardiovascular Surgery, 142(4), 911–920.PubMedCrossRef Donndorf, P., Kundt, G., Kaminski, A., Yerebakan, C., Liebold, A., Steinhoff, G., et al. (2011). Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis. The Journal of Thoracic and Cardiovascular Surgery, 142(4), 911–920.PubMedCrossRef
21.
Zurück zum Zitat Arom, K. V., Ruengsakulrach, P., & Jotisakulratana, V. (2008). Intramyocardial angiogenic cell precursor injection for cardiomyopathy. Asian Cardiovascular and Thoracic Annals, 16(2), 143–148.PubMed Arom, K. V., Ruengsakulrach, P., & Jotisakulratana, V. (2008). Intramyocardial angiogenic cell precursor injection for cardiomyopathy. Asian Cardiovascular and Thoracic Annals, 16(2), 143–148.PubMed
23.
Zurück zum Zitat Lee, W.-Y., Wei, H.-J., Lin, W.-W., Yeh, Y.-C., Hwang, S.-M., Wang, J.-J., et al. (2011). Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM. Biomaterials, 32(24), 5558–5567.PubMedCrossRef Lee, W.-Y., Wei, H.-J., Lin, W.-W., Yeh, Y.-C., Hwang, S.-M., Wang, J.-J., et al. (2011). Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM. Biomaterials, 32(24), 5558–5567.PubMedCrossRef
24.
Zurück zum Zitat Huang, N. F., Yu, J., Sievers, R., Li, S., & Lee, R. J. (2005). Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Engineering, 11(11–12), 1860–1866.PubMedCrossRef Huang, N. F., Yu, J., Sievers, R., Li, S., & Lee, R. J. (2005). Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Engineering, 11(11–12), 1860–1866.PubMedCrossRef
25.
Zurück zum Zitat Christman, K. L., Vardanian, A. J., Fang, Q., Sievers, R. E., Fok, H. H., & Lee, R. J. (2004). Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. Journal of the American College of Cardiology, 44(3), 654–660.PubMedCrossRef Christman, K. L., Vardanian, A. J., Fang, Q., Sievers, R. E., Fok, H. H., & Lee, R. J. (2004). Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. Journal of the American College of Cardiology, 44(3), 654–660.PubMedCrossRef
26.
Zurück zum Zitat Nakamuta, J. S., Danoviz, M. E., Marques, F. L. N., dos Santos, L., Becker, C., Goncalves, G. A., et al. (2009). Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLoS One, 4(6), e6005.PubMedCrossRef Nakamuta, J. S., Danoviz, M. E., Marques, F. L. N., dos Santos, L., Becker, C., Goncalves, G. A., et al. (2009). Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLoS One, 4(6), e6005.PubMedCrossRef
27.
Zurück zum Zitat Strauer, B. E., Brehm, M., Zeus, T., Gattermann, N., Hernandez, A., Sorg, R. V., et al. (2001). Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Deutsche Medizinische Wochenschrift, 126(34–35), 932–938.PubMedCrossRef Strauer, B. E., Brehm, M., Zeus, T., Gattermann, N., Hernandez, A., Sorg, R. V., et al. (2001). Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Deutsche Medizinische Wochenschrift, 126(34–35), 932–938.PubMedCrossRef
28.
Zurück zum Zitat Tuma, J., Fernanadez-Vina, R., Carrasco, A., Castillo, J., Cruz, C., Carrillo, A., et al. (2011). Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina. Journal of Translational Medicine, 9(1), 183. doi:10.1186/1479-5876-9-183.PubMedCrossRef Tuma, J., Fernanadez-Vina, R., Carrasco, A., Castillo, J., Cruz, C., Carrillo, A., et al. (2011). Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina. Journal of Translational Medicine, 9(1), 183. doi:10.​1186/​1479-5876-9-183.PubMedCrossRef
29.
Zurück zum Zitat Moreira Rde, C., Haddad, A. F., Silva, S. A., Souza, A. L., Tuche, F. A., Oliveira, M. A., et al. (2011). Intracoronary stem-cell injection after myocardial infarction: microcirculation sub-study. Arquivos Brasileiros de Cardiologia, 97(5), 420–426.PubMedCrossRef Moreira Rde, C., Haddad, A. F., Silva, S. A., Souza, A. L., Tuche, F. A., Oliveira, M. A., et al. (2011). Intracoronary stem-cell injection after myocardial infarction: microcirculation sub-study. Arquivos Brasileiros de Cardiologia, 97(5), 420–426.PubMedCrossRef
30.
Zurück zum Zitat Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105(1), 93–98. doi:10.1161/hc0102.101442.PubMedCrossRef Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105(1), 93–98. doi:10.​1161/​hc0102.​101442.PubMedCrossRef
31.
Zurück zum Zitat Freyman, T., Polin, G., Osman, H., Crary, J., Lu, M., Cheng, L., et al. (2006). A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. European Heart Journal, 27(9), 1114–1122.PubMedCrossRef Freyman, T., Polin, G., Osman, H., Crary, J., Lu, M., Cheng, L., et al. (2006). A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. European Heart Journal, 27(9), 1114–1122.PubMedCrossRef
32.
Zurück zum Zitat Goussetis, E., Manginas, A., Koutelou, M., Peristeri, I., Theodosaki, M., Kollaros, N., et al. (2006). Intracoronary infusion of CD133 Selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution. Stem Cells, 24(10), 2279–2283.PubMedCrossRef Goussetis, E., Manginas, A., Koutelou, M., Peristeri, I., Theodosaki, M., Kollaros, N., et al. (2006). Intracoronary infusion of CD133 Selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution. Stem Cells, 24(10), 2279–2283.PubMedCrossRef
33.
Zurück zum Zitat Fukushima, S., Campbell, N. G., Coppen, S. R., Yamahara, K., Yuen, A. H. Y., Smolenski, R. T., et al. (2011). Quantitative assessment of initial retention of bone marrow mononuclear cells injected into the coronary arteries. The Journal of Heart and Lung Transplantation, 30(2), 227–233. doi:10.1016/j.healun.2010.09.002.PubMedCrossRef Fukushima, S., Campbell, N. G., Coppen, S. R., Yamahara, K., Yuen, A. H. Y., Smolenski, R. T., et al. (2011). Quantitative assessment of initial retention of bone marrow mononuclear cells injected into the coronary arteries. The Journal of Heart and Lung Transplantation, 30(2), 227–233. doi:10.​1016/​j.​healun.​2010.​09.​002.PubMedCrossRef
34.
Zurück zum Zitat Doyle, B., Kemp, B. J., Chareonthaitawee, P., Reed, C., Schmeckpeper, J., Sorajja, P., et al. (2007). Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. Journal of Nuclear Medicine, 48(10), 1708–1714. doi:10.2967/jnumed.107.042838.PubMedCrossRef Doyle, B., Kemp, B. J., Chareonthaitawee, P., Reed, C., Schmeckpeper, J., Sorajja, P., et al. (2007). Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. Journal of Nuclear Medicine, 48(10), 1708–1714. doi:10.​2967/​jnumed.​107.​042838.PubMedCrossRef
35.
36.
Zurück zum Zitat Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., Holschermann, H., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England Journal of Medicine, 355(12), 1210–1221.PubMedCrossRef Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., Holschermann, H., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England Journal of Medicine, 355(12), 1210–1221.PubMedCrossRef
37.
Zurück zum Zitat Assmus, B., Rolf, A., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., et al. (2010). Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circulation. Heart Failure, 3(1), 89–96. doi:10.1161/circheartfailure.108.843243.PubMedCrossRef Assmus, B., Rolf, A., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., et al. (2010). Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circulation. Heart Failure, 3(1), 89–96. doi:10.​1161/​circheartfailure​.​108.​843243.PubMedCrossRef
38.
Zurück zum Zitat Clifford, D. M., Fisher, S. A., Brunskill, S. J., Doree, C., Mathur, A., Watt, S., et al. (2012). Stem cell treatment for acute myocardial infarction. Cochrane Database of Systematic Reviews, 2, CD006536. Clifford, D. M., Fisher, S. A., Brunskill, S. J., Doree, C., Mathur, A., Watt, S., et al. (2012). Stem cell treatment for acute myocardial infarction. Cochrane Database of Systematic Reviews, 2, CD006536.
39.
Zurück zum Zitat Konstam, M. A., Rousseau, M. F., Kronenberg, M. W., Udelson, J. E., Melin, J., Stewart, D., et al. (1992). Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD investigators. Circulation, 86(2), 431–438.PubMedCrossRef Konstam, M. A., Rousseau, M. F., Kronenberg, M. W., Udelson, J. E., Melin, J., Stewart, D., et al. (1992). Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD investigators. Circulation, 86(2), 431–438.PubMedCrossRef
40.
Zurück zum Zitat Seth, S., Bhargava, B., Narang, R., Ray, R., Mohanty, S., Gulati, G., et al. (2010). The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) Trial: a long-term follow-up study. Journal of the American College of Cardiology, 55(15), 1643–1644.PubMedCrossRef Seth, S., Bhargava, B., Narang, R., Ray, R., Mohanty, S., Gulati, G., et al. (2010). The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) Trial: a long-term follow-up study. Journal of the American College of Cardiology, 55(15), 1643–1644.PubMedCrossRef
41.
Zurück zum Zitat Jaiswal, R. K., Jaiswal, N., Bruder, S. P., Mbalaviele, G., Marshak, D. R., & Pittenger, M. F. (2000). Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. Journal of Biological Chemistry, 275(13), 9645–9652. doi:10.1074/jbc.275.13.9645.PubMedCrossRef Jaiswal, R. K., Jaiswal, N., Bruder, S. P., Mbalaviele, G., Marshak, D. R., & Pittenger, M. F. (2000). Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. Journal of Biological Chemistry, 275(13), 9645–9652. doi:10.​1074/​jbc.​275.​13.​9645.PubMedCrossRef
42.
Zurück zum Zitat Bolli, R., Chugh, A. R., D’Amario, D., Loughran, J. H., Stoddard, M. F., Ikram, S., et al. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. The Lancet, 378(9806), 1847–1857.CrossRef Bolli, R., Chugh, A. R., D’Amario, D., Loughran, J. H., Stoddard, M. F., Ikram, S., et al. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. The Lancet, 378(9806), 1847–1857.CrossRef
43.
Zurück zum Zitat Makkar, R. R., Smith, R. R., Cheng, K., Malliaras, K., Thomson, L. E. J., Berman, D., et al. (2012). Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. The Lancet, 379(9819), 895–904.CrossRef Makkar, R. R., Smith, R. R., Cheng, K., Malliaras, K., Thomson, L. E. J., Berman, D., et al. (2012). Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. The Lancet, 379(9819), 895–904.CrossRef
44.
Zurück zum Zitat Tossios, P., Krausgrill, B., Schmidt, M., Fischer, T., Halbach, M., Fries, J. W., et al. (2008). Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction. European Heart Journal, 29(15), 1911–1921.PubMedCrossRef Tossios, P., Krausgrill, B., Schmidt, M., Fischer, T., Halbach, M., Fries, J. W., et al. (2008). Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction. European Heart Journal, 29(15), 1911–1921.PubMedCrossRef
45.
Zurück zum Zitat Yao, K., Huang, R., Sun, A., Qian, J., Liu, X., Ge, L., et al. (2009). Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction. European Journal of Heart Failure, 11(7), 691–698. doi:10.1093/eurjhf/hfp062.PubMedCrossRef Yao, K., Huang, R., Sun, A., Qian, J., Liu, X., Ge, L., et al. (2009). Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction. European Journal of Heart Failure, 11(7), 691–698. doi:10.​1093/​eurjhf/​hfp062.PubMedCrossRef
46.
Zurück zum Zitat Gu, X. A., Xie, Y., Gu, J. A., Sun, L., He, S. H., Xu, R. X., et al. (2011). Repeated intracoronary infusion of peripheral blood stem cells with G-CSF in patients with refractory ischemic heart failure—a pilot study. Circulation Journal, 75(4), 955–963. doi:10.1253/circj.CJ-10-0898.PubMedCrossRef Gu, X. A., Xie, Y., Gu, J. A., Sun, L., He, S. H., Xu, R. X., et al. (2011). Repeated intracoronary infusion of peripheral blood stem cells with G-CSF in patients with refractory ischemic heart failure—a pilot study. Circulation Journal, 75(4), 955–963. doi:10.​1253/​circj.​CJ-10-0898.PubMedCrossRef
47.
Zurück zum Zitat Kang, H.-J., Lee, H.-Y., Na, S.-H., Chang, S.-A., Park, K.-W., Kim, H.-K., et al. (2006). Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation, 114(1_suppl), I-145–I-151. doi:10.1161/circulationaha.105.001107.CrossRef Kang, H.-J., Lee, H.-Y., Na, S.-H., Chang, S.-A., Park, K.-W., Kim, H.-K., et al. (2006). Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation, 114(1_suppl), I-145–I-151. doi:10.​1161/​circulationaha.​105.​001107.CrossRef
48.
Zurück zum Zitat Pasha, Z., Wang, Y., Sheikh, R., Zhang, D., Zhao, T., & Ashraf, M. (2008). Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovascular Research, 77(1), 134–142. doi:10.1093/cvr/cvm025.PubMedCrossRef Pasha, Z., Wang, Y., Sheikh, R., Zhang, D., Zhao, T., & Ashraf, M. (2008). Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovascular Research, 77(1), 134–142. doi:10.​1093/​cvr/​cvm025.PubMedCrossRef
49.
Zurück zum Zitat Pons, J., Huang, Y., Arakawa-Hoyt, J., Washko, D., Takagawa, J., Ye, J., et al. (2008). VEGF improves survival of mesenchymal stem cells in infarcted hearts. Biochemical and Biophysical Research Communications, 376(2), 419–422.PubMedCrossRef Pons, J., Huang, Y., Arakawa-Hoyt, J., Washko, D., Takagawa, J., Ye, J., et al. (2008). VEGF improves survival of mesenchymal stem cells in infarcted hearts. Biochemical and Biophysical Research Communications, 376(2), 419–422.PubMedCrossRef
50.
Zurück zum Zitat Ryzhov, S., Solenkova, N. V., Goldstein, A. E., Lamparter, M., Fleenor, T., Young, P. P., et al. (2008). Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells. Circulation Research, 102(3), 356–363. doi:10.1161/circresaha.107.158147.PubMedCrossRef Ryzhov, S., Solenkova, N. V., Goldstein, A. E., Lamparter, M., Fleenor, T., Young, P. P., et al. (2008). Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells. Circulation Research, 102(3), 356–363. doi:10.​1161/​circresaha.​107.​158147.PubMedCrossRef
52.
Zurück zum Zitat Forest, V. F., Tirouvanziam, A. M., Perigaud, C., Fernandes, S., Fusellier, M. S., Desfontis, J. C., et al. (2010). Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials. Stem Cell Research and Therapy, 1(1), 4. doi:10.1186/scrt4.PubMedCrossRef Forest, V. F., Tirouvanziam, A. M., Perigaud, C., Fernandes, S., Fusellier, M. S., Desfontis, J. C., et al. (2010). Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials. Stem Cell Research and Therapy, 1(1), 4. doi:10.​1186/​scrt4.PubMedCrossRef
53.
Zurück zum Zitat Brenner, W., Aicher, A., Eckey, T., Massoudi, S., Zuhayra, M., Koehl, U., et al. (2004). 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. Journal of Nuclear Medicine, 45(3), 512–518.PubMed Brenner, W., Aicher, A., Eckey, T., Massoudi, S., Zuhayra, M., Koehl, U., et al. (2004). 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. Journal of Nuclear Medicine, 45(3), 512–518.PubMed
54.
Zurück zum Zitat Kang, W. J., Kang, H. J., Kim, H. S., Chung, J. K., Lee, M. C., & Lee, D. S. (2006). Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. Journal of Nuclear Medicine, 47(8), 1295–1301.PubMed Kang, W. J., Kang, H. J., Kim, H. S., Chung, J. K., Lee, M. C., & Lee, D. S. (2006). Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. Journal of Nuclear Medicine, 47(8), 1295–1301.PubMed
55.
Zurück zum Zitat Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., et al. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54(24), 2277–2286.PubMedCrossRef Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., et al. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54(24), 2277–2286.PubMedCrossRef
56.
Zurück zum Zitat Nagaya, N., Fujii, T., Iwase, T., Ohgushi, H., Itoh, T., Uematsu, M., et al. (2004). Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. American Journal of Physiology - Heart and Circulatory Physiology, 287(6), H2670–H2676. doi:10.1152/ajpheart.01071.2003.PubMedCrossRef Nagaya, N., Fujii, T., Iwase, T., Ohgushi, H., Itoh, T., Uematsu, M., et al. (2004). Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. American Journal of Physiology - Heart and Circulatory Physiology, 287(6), H2670–H2676. doi:10.​1152/​ajpheart.​01071.​2003.PubMedCrossRef
58.
Zurück zum Zitat Chiu, L. L., Iyer, R. K., Reis, L. A., Nunes, S. S., & Radisic, M. (2012). Cardiac tissue engineering: current state and perspectives. Frontiers in Bioscience: a Journal and Virtual Library, 17, 1533–1550.CrossRef Chiu, L. L., Iyer, R. K., Reis, L. A., Nunes, S. S., & Radisic, M. (2012). Cardiac tissue engineering: current state and perspectives. Frontiers in Bioscience: a Journal and Virtual Library, 17, 1533–1550.CrossRef
59.
Zurück zum Zitat Elloumi-Hannachi, I., Yamato, M., & Okano, T. (2010). Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine. Journal of Internal Medicine, 267(1), 54–70.PubMedCrossRef Elloumi-Hannachi, I., Yamato, M., & Okano, T. (2010). Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine. Journal of Internal Medicine, 267(1), 54–70.PubMedCrossRef
60.
Zurück zum Zitat Yang, J., Yamato, M., Kohno, C., Nishimoto, A., Sekine, H., Fukai, F., et al. (2005). Cell sheet engineering: recreating tissues without biodegradable scaffolds. Biomaterials, 26(33), 6415–6422.PubMedCrossRef Yang, J., Yamato, M., Kohno, C., Nishimoto, A., Sekine, H., Fukai, F., et al. (2005). Cell sheet engineering: recreating tissues without biodegradable scaffolds. Biomaterials, 26(33), 6415–6422.PubMedCrossRef
61.
Zurück zum Zitat Sekine, H., Shimizu, T., Kosaka, S., Kobayashi, E., & Okano, T. (2006). Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells. The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation, 25(3), 324–332.CrossRef Sekine, H., Shimizu, T., Kosaka, S., Kobayashi, E., & Okano, T. (2006). Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells. The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation, 25(3), 324–332.CrossRef
62.
Zurück zum Zitat Miyahara, Y., Nagaya, N., Kataoka, M., Yanagawa, B., Tanaka, K., Hao, H., et al. (2006). Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nature Medicine, 12(4), 459–465.PubMedCrossRef Miyahara, Y., Nagaya, N., Kataoka, M., Yanagawa, B., Tanaka, K., Hao, H., et al. (2006). Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nature Medicine, 12(4), 459–465.PubMedCrossRef
63.
Zurück zum Zitat Matsuura, K., Honda, A., Nagai, T., Fukushima, N., Iwanaga, K., Tokunaga, M., et al. (2009). Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. The Journal of Clinical Investigation, 119(8), 2204–2217.PubMed Matsuura, K., Honda, A., Nagai, T., Fukushima, N., Iwanaga, K., Tokunaga, M., et al. (2009). Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. The Journal of Clinical Investigation, 119(8), 2204–2217.PubMed
64.
Zurück zum Zitat Bel, A., Planat-Bernard, V., Saito, A., Bonnevie, L., Bellamy, V., Sabbah, L., et al. (2010). Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation, 122(11 suppl 1), S118–S123. doi:10.1161/circulationaha.109.927293.PubMedCrossRef Bel, A., Planat-Bernard, V., Saito, A., Bonnevie, L., Bellamy, V., Sabbah, L., et al. (2010). Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation, 122(11 suppl 1), S118–S123. doi:10.​1161/​circulationaha.​109.​927293.PubMedCrossRef
65.
Zurück zum Zitat Memon, I. A., Sawa, Y., Fukushima, N., Matsumiya, G., Miyagawa, S., Taketani, S., et al. (2005). Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. The Journal of Thoracic and Cardiovascular Surgery, 130(5), 1333–1341.PubMedCrossRef Memon, I. A., Sawa, Y., Fukushima, N., Matsumiya, G., Miyagawa, S., Taketani, S., et al. (2005). Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. The Journal of Thoracic and Cardiovascular Surgery, 130(5), 1333–1341.PubMedCrossRef
66.
Zurück zum Zitat Miyagawa, S., Saito, A., Sakaguchi, T., Yoshikawa, Y., Yamauchi, T., Imanishi, Y., et al. (2010). Impaired myocardium regeneration with skeletal cell sheets—a preclinical trial for tissue-engineered regeneration therapy. Transplantation, 90(4), 364–372. doi:10.1097/TP.0b013e3181e6f201.PubMedCrossRef Miyagawa, S., Saito, A., Sakaguchi, T., Yoshikawa, Y., Yamauchi, T., Imanishi, Y., et al. (2010). Impaired myocardium regeneration with skeletal cell sheets—a preclinical trial for tissue-engineered regeneration therapy. Transplantation, 90(4), 364–372. doi:10.​1097/​TP.​0b013e3181e6f201​.PubMedCrossRef
67.
Zurück zum Zitat Yeo, C., & Mathur, A. (2009). Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial. Regenerative Medicine, 4(1), 119–127.PubMedCrossRef Yeo, C., & Mathur, A. (2009). Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial. Regenerative Medicine, 4(1), 119–127.PubMedCrossRef
68.
Zurück zum Zitat Stamm, C., Kleine, H.-D., Choi, Y. H., Dunkelmann, S., Lauffs, J. A., Lorenzen, B., et al. (2007). Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. The Journal of Thoracic and Cardiovascular Surgery, 133(3), 717–725.PubMedCrossRef Stamm, C., Kleine, H.-D., Choi, Y. H., Dunkelmann, S., Lauffs, J. A., Lorenzen, B., et al. (2007). Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. The Journal of Thoracic and Cardiovascular Surgery, 133(3), 717–725.PubMedCrossRef
69.
Zurück zum Zitat Patel, A. N., Geffner, L., Vina, R. F., Saslavsky, J., Urschel, H. C., Kormos, R., et al. (2005). Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. The Journal of Thoracic and Cardiovascular Surgery, 130(6), 1631–1638.PubMedCrossRef Patel, A. N., Geffner, L., Vina, R. F., Saslavsky, J., Urschel, H. C., Kormos, R., et al. (2005). Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. The Journal of Thoracic and Cardiovascular Surgery, 130(6), 1631–1638.PubMedCrossRef
70.
Zurück zum Zitat Mocini, D., Staibano, M., Mele, L., Giannantoni, P., Menichella, G., Colivicchi, F., et al. (2006). Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting. American Heart Journal, 151(1), 192–197.PubMedCrossRef Mocini, D., Staibano, M., Mele, L., Giannantoni, P., Menichella, G., Colivicchi, F., et al. (2006). Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting. American Heart Journal, 151(1), 192–197.PubMedCrossRef
71.
Zurück zum Zitat Hendrikx, M., Hensen, K., Clijsters, C., Jongen, H., Koninckx, R., Bijnens, E., et al. (2006). Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation. Circulation, 114(1 suppl), I-101–I-107. doi:10.1161/circulationaha.105.000505.CrossRef Hendrikx, M., Hensen, K., Clijsters, C., Jongen, H., Koninckx, R., Bijnens, E., et al. (2006). Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation. Circulation, 114(1 suppl), I-101–I-107. doi:10.​1161/​circulationaha.​105.​000505.CrossRef
72.
Zurück zum Zitat Ang, K.-L., Chin, D., Leyva, F., Foley, P., Kubal, C., Chalil, S., et al. (2008). Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nature Clinical Practice. Cardiovascular Medicine, 5(10), 663–670.PubMedCrossRef Ang, K.-L., Chin, D., Leyva, F., Foley, P., Kubal, C., Chalil, S., et al. (2008). Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nature Clinical Practice. Cardiovascular Medicine, 5(10), 663–670.PubMedCrossRef
73.
Zurück zum Zitat Yerebakan, C., Kaminski, A., Westphal, B., Donndorf, P., Glass, A., Liebold, A., et al. (2011). Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133+ bone marrow stem cell transplant. The Journal of Thoracic and Cardiovascular Surgery, 142(6), 1530.e3–1539.e3.CrossRef Yerebakan, C., Kaminski, A., Westphal, B., Donndorf, P., Glass, A., Liebold, A., et al. (2011). Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133+ bone marrow stem cell transplant. The Journal of Thoracic and Cardiovascular Surgery, 142(6), 1530.e3–1539.e3.CrossRef
74.
Zurück zum Zitat Perin, E. C., Dohmann, H. F. R., Borojevic, R., Silva, S. A., Sousa, A. L. S., Silva, G. V., et al. (2004). Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation, 110(11 suppl 1), II-213–II-218. doi:10.1161/01.cir.0000138398.77550.62.CrossRef Perin, E. C., Dohmann, H. F. R., Borojevic, R., Silva, S. A., Sousa, A. L. S., Silva, G. V., et al. (2004). Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation, 110(11 suppl 1), II-213–II-218. doi:10.​1161/​01.​cir.​0000138398.​77550.​62.CrossRef
75.
Zurück zum Zitat Beeres, S. L. M. A., Bax, J. J., Kaandorp, T. A. M., Zeppenfeld, K., Lamb, H. J., Dibbets-Schneider, P., et al. (2006). Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia. The American Journal of Cardiology, 97(9), 1326–1331.PubMedCrossRef Beeres, S. L. M. A., Bax, J. J., Kaandorp, T. A. M., Zeppenfeld, K., Lamb, H. J., Dibbets-Schneider, P., et al. (2006). Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia. The American Journal of Cardiology, 97(9), 1326–1331.PubMedCrossRef
76.
Zurück zum Zitat Fuchs, S., Kornowski, R., Weisz, G., Satler, L. F., Smits, P. C., Okubagzi, P., et al. (2006). Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. The American Journal of Cardiology, 97(6), 823–829.PubMedCrossRef Fuchs, S., Kornowski, R., Weisz, G., Satler, L. F., Smits, P. C., Okubagzi, P., et al. (2006). Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. The American Journal of Cardiology, 97(6), 823–829.PubMedCrossRef
77.
Zurück zum Zitat Dib, N., Dinsmore, J., Lababidi, Z., White, B., Moravec, S., Campbell, A., et al. (2009). One-year follow-up of feasibility and safety of the first us, randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC Study). JACC. Cardiovascular Interventions, 2(1), 9–16. doi:10.1016/j.jcin.2008.11.003.PubMedCrossRef Dib, N., Dinsmore, J., Lababidi, Z., White, B., Moravec, S., Campbell, A., et al. (2009). One-year follow-up of feasibility and safety of the first us, randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC Study). JACC. Cardiovascular Interventions, 2(1), 9–16. doi:10.​1016/​j.​jcin.​2008.​11.​003.PubMedCrossRef
78.
Zurück zum Zitat Williams, A. R., Trachtenberg, B., Velazquez, D. L., McNiece, I., Altman, P., Rouy, D., et al. (2011). Intramyocardial stem cell injection in patients with ischemic cardiomyopathy/novelty and significance. Circulation Research, 108(7), 792–796. doi:10.1161/circresaha.111.242610.PubMedCrossRef Williams, A. R., Trachtenberg, B., Velazquez, D. L., McNiece, I., Altman, P., Rouy, D., et al. (2011). Intramyocardial stem cell injection in patients with ischemic cardiomyopathy/novelty and significance. Circulation Research, 108(7), 792–796. doi:10.​1161/​circresaha.​111.​242610.PubMedCrossRef
79.
Zurück zum Zitat Perin, E. C., Silva, G. V., Henry, T. D., Cabreira-Hansen, M. G., Moore, W. H., Coulter, S. A., et al. (2011). A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). American Heart Journal, 161(6), 1078.e3–1087.e3.CrossRef Perin, E. C., Silva, G. V., Henry, T. D., Cabreira-Hansen, M. G., Moore, W. H., Coulter, S. A., et al. (2011). A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). American Heart Journal, 161(6), 1078.e3–1087.e3.CrossRef
80.
Zurück zum Zitat Povsic, T. J., O’Connor, C. M., Henry, T., Taussig, A., Kereiakes, D. J., Fortuin, F. D., et al. (2011). A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. American Heart Journal, 162(4), 654.e1–662.e1.CrossRef Povsic, T. J., O’Connor, C. M., Henry, T., Taussig, A., Kereiakes, D. J., Fortuin, F. D., et al. (2011). A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. American Heart Journal, 162(4), 654.e1–662.e1.CrossRef
81.
Zurück zum Zitat Duckers, H. J., Houtgraaf, J., Hehrlein, C., Schofer, J., Waltenberger, J., Gershlick, A., et al. (2011). Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention, 6(7), 805–812. doi:10.4244/eijv6i7a139.PubMedCrossRef Duckers, H. J., Houtgraaf, J., Hehrlein, C., Schofer, J., Waltenberger, J., Gershlick, A., et al. (2011). Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention, 6(7), 805–812. doi:10.​4244/​eijv6i7a139.PubMedCrossRef
82.
Zurück zum Zitat Strauer, B. E., Brehm, M., Zeus, T., Kostering, M., Hernandez, A., Sorg, R. V., et al. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 106(15), 1913–1918.PubMedCrossRef Strauer, B. E., Brehm, M., Zeus, T., Kostering, M., Hernandez, A., Sorg, R. V., et al. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 106(15), 1913–1918.PubMedCrossRef
83.
Zurück zum Zitat Schachinger, V., Assmus, B., Britten, M. B., Honold, J., Lehmann, R., Teupe, C., et al. (2004). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. Journal of the American College of Cardiology, 44(8), 1690–1699.PubMedCrossRef Schachinger, V., Assmus, B., Britten, M. B., Honold, J., Lehmann, R., Teupe, C., et al. (2004). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. Journal of the American College of Cardiology, 44(8), 1690–1699.PubMedCrossRef
84.
Zurück zum Zitat Chen, S. L., Fang, W. W., Ye, F., Liu, Y. H., Qian, J., Shan, S. J., et al. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. The American Journal of Cardiology, 94(1), 92–95.PubMedCrossRef Chen, S. L., Fang, W. W., Ye, F., Liu, Y. H., Qian, J., Shan, S. J., et al. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. The American Journal of Cardiology, 94(1), 92–95.PubMedCrossRef
85.
Zurück zum Zitat Wollert, K. C., Meyer, G. P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364(9429), 141–148.PubMedCrossRef Wollert, K. C., Meyer, G. P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364(9429), 141–148.PubMedCrossRef
86.
Zurück zum Zitat Ruan, W., Pan, C. Z., Huang, G. Q., Li, Y. L., Ge, J. B., & Shu, X. H. (2005). Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging. Chinese Medical Journal, 118(14), 1175–1181.PubMed Ruan, W., Pan, C. Z., Huang, G. Q., Li, Y. L., Ge, J. B., & Shu, X. H. (2005). Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging. Chinese Medical Journal, 118(14), 1175–1181.PubMed
87.
Zurück zum Zitat Strauer, B. E., Brehm, M., Zeus, T., Bartsch, T., Schannwell, C., Antke, C., et al. (2005). Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. Journal of the American College of Cardiology, 46(9), 1651–1658.PubMedCrossRef Strauer, B. E., Brehm, M., Zeus, T., Bartsch, T., Schannwell, C., Antke, C., et al. (2005). Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. Journal of the American College of Cardiology, 46(9), 1651–1658.PubMedCrossRef
88.
Zurück zum Zitat Ge, J., Li, Y., Qian, J., Shi, J., Wang, Q., Niu, Y., et al. (2006). Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart, 92(12), 1764–1767.PubMedCrossRef Ge, J., Li, Y., Qian, J., Shi, J., Wang, Q., Niu, Y., et al. (2006). Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart, 92(12), 1764–1767.PubMedCrossRef
89.
Zurück zum Zitat Janssens, S., Dubois, C., Bogaert, J., Theunissen, K., Deroose, C., Desmet, W., et al. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. The Lancet, 367(9505), 113–121.CrossRef Janssens, S., Dubois, C., Bogaert, J., Theunissen, K., Deroose, C., Desmet, W., et al. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. The Lancet, 367(9505), 113–121.CrossRef
90.
Zurück zum Zitat Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. The New England Journal of Medicine, 355(12), 1199–1209.PubMedCrossRef Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. The New England Journal of Medicine, 355(12), 1199–1209.PubMedCrossRef
91.
Zurück zum Zitat Assmus, B., Honold, J., Schachinger, V., Britten, M. B., Fischer-Rasokat, U., Lehmann, R., et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. The New England Journal of Medicine, 355(12), 1222–1232. doi:10.1056/NEJMoa051779.PubMedCrossRef Assmus, B., Honold, J., Schachinger, V., Britten, M. B., Fischer-Rasokat, U., Lehmann, R., et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. The New England Journal of Medicine, 355(12), 1222–1232. doi:10.​1056/​NEJMoa051779.PubMedCrossRef
92.
Zurück zum Zitat Penicka, M., Horak, J., Kobylka, P., Pytlik, R., Kozak, T., Belohlavek, O., et al. (2007). Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study. Journal of the American College of Cardiology, 49(24), 2373–2374.PubMedCrossRef Penicka, M., Horak, J., Kobylka, P., Pytlik, R., Kozak, T., Belohlavek, O., et al. (2007). Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study. Journal of the American College of Cardiology, 49(24), 2373–2374.PubMedCrossRef
93.
Zurück zum Zitat Li, Z. Q., Zhang, M., Jing, Y. Z., Zhang, W. W., Liu, Y., Cui, L. J., et al. (2007). The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). International Journal of Cardiology, 115(1), 52–56.PubMedCrossRef Li, Z. Q., Zhang, M., Jing, Y. Z., Zhang, W. W., Liu, Y., Cui, L. J., et al. (2007). The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). International Journal of Cardiology, 115(1), 52–56.PubMedCrossRef
94.
Zurück zum Zitat Tatsumi, T., Ashihara, E., Yasui, T., Matsunaga, S., Kido, A., Sasada, Y., et al. (2007). Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circulation Journal, 71(8), 1199–1207.PubMedCrossRef Tatsumi, T., Ashihara, E., Yasui, T., Matsunaga, S., Kido, A., Sasada, Y., et al. (2007). Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circulation Journal, 71(8), 1199–1207.PubMedCrossRef
95.
Zurück zum Zitat Huikuri, H. V., Kervinen, K., Niemela, M., Ylitalo, K., Saily, M., Koistinen, P., et al. (2008). Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. European Heart Journal, 29(22), 2273–2737.CrossRef Huikuri, H. V., Kervinen, K., Niemela, M., Ylitalo, K., Saily, M., Koistinen, P., et al. (2008). Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. European Heart Journal, 29(22), 2273–2737.CrossRef
96.
Zurück zum Zitat Meluzin, J., Janousek, S., Mayer, J., Groch, L., Hornacek, I., Hlinomaz, O., et al. (2008). Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. International Journal of Cardiology, 128(2), 185–192.PubMedCrossRef Meluzin, J., Janousek, S., Mayer, J., Groch, L., Hornacek, I., Hlinomaz, O., et al. (2008). Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. International Journal of Cardiology, 128(2), 185–192.PubMedCrossRef
97.
Zurück zum Zitat Plewka, M., Krzeminska-Pakula, M., Peruga, J. Z., Lipiec, P., Kurpesa, M., Wierzbowska-Drabik, K., et al. (2009). The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results. Kardiologia Polska, 69(12), 1234–1240. Plewka, M., Krzeminska-Pakula, M., Peruga, J. Z., Lipiec, P., Kurpesa, M., Wierzbowska-Drabik, K., et al. (2009). The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results. Kardiologia Polska, 69(12), 1234–1240.
98.
Zurück zum Zitat Cao, F., Sun, D., Li, C., Narsinh, K., Zhao, L., Li, X., et al. (2009). Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. European Heart Journal, 30(16), 1986–1994.PubMedCrossRef Cao, F., Sun, D., Li, C., Narsinh, K., Zhao, L., Li, X., et al. (2009). Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. European Heart Journal, 30(16), 1986–1994.PubMedCrossRef
99.
Zurück zum Zitat Tendera, M., Wojakowski, W., Ruzyllo, W., Chojnowska, L., Kepka, C., Tracz, W., et al. (2009). Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. European Heart Journal, 30(11), 1313–1321. doi:10.1093/eurheartj/ehp073.PubMedCrossRef Tendera, M., Wojakowski, W., Ruzyllo, W., Chojnowska, L., Kepka, C., Tracz, W., et al. (2009). Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. European Heart Journal, 30(11), 1313–1321. doi:10.​1093/​eurheartj/​ehp073.PubMedCrossRef
100.
Zurück zum Zitat Yousef, M., Schannwell, C. M., Kostering, M., Zeus, T., Brehm, M., & Strauer, B. E. (2009). The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. Journal of the American College of Cardiology, 53(24), 2262–2269. doi:10.1016/j.jacc.2009.02.051.PubMedCrossRef Yousef, M., Schannwell, C. M., Kostering, M., Zeus, T., Brehm, M., & Strauer, B. E. (2009). The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. Journal of the American College of Cardiology, 53(24), 2262–2269. doi:10.​1016/​j.​jacc.​2009.​02.​051.PubMedCrossRef
101.
Zurück zum Zitat Grajek, S., Popiel, M., Gil, L., Breborowicz, P., Lesiak, M., Czepczynski, R., et al. (2010). Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation. European Heart Journal, 31(6), 691–702.PubMedCrossRef Grajek, S., Popiel, M., Gil, L., Breborowicz, P., Lesiak, M., Czepczynski, R., et al. (2010). Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation. European Heart Journal, 31(6), 691–702.PubMedCrossRef
102.
Zurück zum Zitat Strauer, B.-E., Yousef, M., & Schannwell, C. M. (2010). The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heARt failure: the STAR-heart study. European Journal of Heart Failure, 12(7), 721–729. doi:10.1093/eurjhf/hfq095.PubMedCrossRef Strauer, B.-E., Yousef, M., & Schannwell, C. M. (2010). The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heARt failure: the STAR-heart study. European Journal of Heart Failure, 12(7), 721–729. doi:10.​1093/​eurjhf/​hfq095.PubMedCrossRef
103.
Zurück zum Zitat Suarez de Lezo, J., Herrera, C., Pan, M., Romero, M., Pavlovic, D., Segura, J., et al. (2007). Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function. Revista Española de Cardiología, 60(4), 357–365.PubMedCrossRef Suarez de Lezo, J., Herrera, C., Pan, M., Romero, M., Pavlovic, D., Segura, J., et al. (2007). Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function. Revista Española de Cardiología, 60(4), 357–365.PubMedCrossRef
104.
Zurück zum Zitat Piepoli, M. F., Vallisa, D., Arbasi, M., Cavanna, L., Cerri, L., Mori, M., et al. (2010). Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). European Journal of Heart Failure, 12(2), 172–180. doi:10.1093/eurjhf/hfp183.PubMedCrossRef Piepoli, M. F., Vallisa, D., Arbasi, M., Cavanna, L., Cerri, L., Mori, M., et al. (2010). Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). European Journal of Heart Failure, 12(2), 172–180. doi:10.​1093/​eurjhf/​hfp183.PubMedCrossRef
105.
Zurück zum Zitat Wohrle, J., Merkle, N., Mailander, V., Nusser, T., Schauwecker, P., von Scheidt, F., et al. (2010). Results of intracoronary stem cell therapy after acute myocardial infarction. The American Journal of Cardiology, 105(6), 804–812.PubMedCrossRef Wohrle, J., Merkle, N., Mailander, V., Nusser, T., Schauwecker, P., von Scheidt, F., et al. (2010). Results of intracoronary stem cell therapy after acute myocardial infarction. The American Journal of Cardiology, 105(6), 804–812.PubMedCrossRef
106.
Zurück zum Zitat Hirsch, A., Nijveldt, R., van der Vleuten, P. A., Tijssen, J. G. P., van der Giessen, W. J., Tio, R. A., et al. (2011). Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. European Heart Journal, 32(14), 1736–1747. doi:10.1093/eurheartj/ehq449.PubMedCrossRef Hirsch, A., Nijveldt, R., van der Vleuten, P. A., Tijssen, J. G. P., van der Giessen, W. J., Tio, R. A., et al. (2011). Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. European Heart Journal, 32(14), 1736–1747. doi:10.​1093/​eurheartj/​ehq449.PubMedCrossRef
107.
Zurück zum Zitat Roncalli, J., Mouquet, F., Piot, C., Trochu, J.-N., Le Corvoisier, P., Neuder, Y., et al. (2011). Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. European Heart Journal, 32(14), 1748–1757. doi:10.1093/eurheartj/ehq455.PubMedCrossRef Roncalli, J., Mouquet, F., Piot, C., Trochu, J.-N., Le Corvoisier, P., Neuder, Y., et al. (2011). Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. European Heart Journal, 32(14), 1748–1757. doi:10.​1093/​eurheartj/​ehq455.PubMedCrossRef
108.
Zurück zum Zitat Traverse, J. H., Henry, T. D., Ellis, S. G., Pepine, C. J., Willerson, J. T., Zhao, D. X. M., et al. (2011). Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function. JAMA: The Journal of the American Medical Association, 306(19), 2110–2119. doi:10.1001/jama.2011.1670.CrossRef Traverse, J. H., Henry, T. D., Ellis, S. G., Pepine, C. J., Willerson, J. T., Zhao, D. X. M., et al. (2011). Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function. JAMA: The Journal of the American Medical Association, 306(19), 2110–2119. doi:10.​1001/​jama.​2011.​1670.CrossRef
109.
Zurück zum Zitat Quyyumi, A. A., Waller, E. K., Murrow, J., Esteves, F., Galt, J., Oshinski, J., et al. (2011). CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. American Heart Journal, 161(1), 98–105.PubMedCrossRef Quyyumi, A. A., Waller, E. K., Murrow, J., Esteves, F., Galt, J., Oshinski, J., et al. (2011). CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. American Heart Journal, 161(1), 98–105.PubMedCrossRef
Metadaten
Titel
Cell Delivery Routes for Stem Cell Therapy to the Heart: Current and Future Approaches
verfasst von
Niall G. Campbell
Ken Suzuki
Publikationsdatum
01.10.2012
Verlag
Springer US
Erschienen in
Journal of Cardiovascular Translational Research / Ausgabe 5/2012
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-012-9378-3

Weitere Artikel der Ausgabe 5/2012

Journal of Cardiovascular Translational Research 5/2012 Zur Ausgabe

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.